Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant

Expert Rev Neurother. 2023 Feb;23(2):179-186. doi: 10.1080/14737175.2023.2185138. Epub 2023 Mar 1.

Abstract

Introduction: COVID19 associated headaches are highly common and there is currently an unmet need to better understand their association with SARSCoV2 variants. Headaches are a prevalent symptom in the acute phase of COVID19 and are associated with a better prognosis and better immune response. They are also a relevant post-COVID symptom.

Areas covered: This article analyses the differences in the prevalence of headache as an onset symptom and in post-COVID headache among the different SARS-CoV-2 variants: the historical strain, Alpha, Delta and Omicron. The different pathophysiological mechanisms by which SARS-CoV-2 infection may cause headache are also discussed.

Expert opinion: The presence of headache at the acute phase is a risk factor for post-COVID headache, whereas a history of primary headache does not appear to be associated with post-COVID headache. The prevalence of headache as an onset symptom appears to be variable for the different SARS-CoV-2 variants, but current data are inconclusive. However, the current evidence also suggests that headache represents a prevalent symptom in the acute and post-infection COVID-19 phase, regardless of SARS-CoV-2 variant.

Keywords: COVID-19; Headache; SARS-CoV-2; long COVID; post-COVID; variant.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Disease
  • Animals
  • COVID-19* / complications
  • COVID-19* / physiopathology
  • COVID-19* / virology
  • Headache* / etiology
  • Headache* / physiopathology
  • Headache* / virology
  • Humans
  • Post-Acute COVID-19 Syndrome* / complications
  • Post-Acute COVID-19 Syndrome* / physiopathology
  • Post-Acute COVID-19 Syndrome* / virology
  • Risk Factors

Supplementary concepts

  • SARS-CoV-2 variants